Breast cancer does not have a single cause. It develops from a collision of inherited genetic risk, hormonal exposure across a woman’s lifetime, and modifiable factors like body weight, physical activity, alcohol intake, and environmental chemicals. The relative weight of each factor varies from person to person, and even from one molecular subtype of breast cancer to another. Understanding how these threads weave together helps explain why some women with no obvious risk factors get breast cancer while others with several risk factors never do.
Inherited Genetic Risk
The most widely recognized genetic risk factors are mutations in the BRCA1 and BRCA2 genes. These genes normally function as tumor suppressors, helping cells repair damaged DNA and maintain chromosomal stability.1PubMed Central. Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage When either gene carries a harmful mutation, the cell’s ability to fix broken DNA is compromised, and the risk of breast and ovarian cancer rises sharply. Women with a BRCA1 mutation face a lifetime breast cancer risk that can exceed 70 percent, and BRCA2 carriers are in a similar range, though the exact numbers depend on family history and other modifiers.
BRCA mutations get the headlines, but they account for a relatively small share of all breast cancers. A larger group of women carry mutations in moderate-risk genes like CHEK2 and ATM. These don’t carry the same dramatic risk as BRCA, and the actual lifetime risk for carriers varies widely depending on other factors. One study found that when researchers combined genetic variant status with a polygenic risk score and a clinical risk model, only about 12 percent of CHEK2 carriers and 10 percent of ATM carriers fell into a high-risk category (above 50 percent lifetime risk), while roughly a quarter to a third had a low estimated risk comparable to the general population.2PubMed Central. Comprehensive Breast Cancer Risk Assessment for CHEK2 and ATM Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick Model That spread matters clinically because it means carrying a moderate-risk gene variant is not, by itself, a sentence.
Beyond single-gene mutations, researchers now use polygenic risk scores that tally the combined effect of hundreds of common genetic variants, each contributing a tiny amount of risk. A score built from 313 such variants was found to significantly predict breast cancer in families already at elevated risk, and incorporating it into existing risk models would have changed screening recommendations for more than a quarter of those women.3Journal of Medical Genetics. Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases Separately, a large study found that a high polygenic risk score (above the 90th percentile) conferred a risk increase comparable in size to having a strong family history, and women with a low score (below the 10th percentile) had reduced risk of both interval and screen-detected cancers.4PubMed. Comprehensive Inherited Risk Estimation for Risk-Based Breast Cancer Screening in Women The practical implication is that genetic risk sits on a spectrum, not a binary of “BRCA-positive” versus “no risk.”
Hormones the Body Makes
Estrogen is the most studied hormonal driver of breast cancer. Breast cells have estrogen receptors, and when estrogen binds to them, it promotes cell division. More division means more chances for a copying error that could start a tumor. For decades, the assumption was simple: the more total years of estrogen exposure (early first period, late menopause, no pregnancies), the higher the risk. That framework is not wrong, but newer epidemiological data suggest that timing matters at least as much as total duration. Early menarche, which exposes developing breast tissue to estrogen at a younger and more vulnerable stage, appears to have a bigger impact on risk than late menopause does.5PubMed Central. Estrogen Effects on the Mammary Gland in Early and Late Life and Breast Cancer Risk
Pregnancy illustrates the complexity. During pregnancy, estrogen levels skyrocket, yet pregnancy reduces long-term breast cancer risk. The likely explanation is that pregnancy pushes breast cells into a more mature, fully differentiated state that is less susceptible to damage. This paradox reinforces the idea that when hormones act on which cells matters more than just how much hormone is circulating.
Hormone Therapy and Oral Contraceptives
Menopausal hormone therapy (HT) is one of the most thoroughly studied external hormone exposures. The evidence consistently shows that the type of progestogen combined with estrogen makes a significant difference. A large French cohort study found that estrogen combined with synthetic progestins carried a clearly elevated risk, while estrogen paired with micronized (natural) progesterone did not show a statistically significant increase, even after a few years of use.6PubMed. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort Other European data found even sharper differences based on the dosing schedule: continuous combined regimens (where estrogen and progestin are taken every day together) carried a higher risk than cyclical regimens, with continuous use roughly doubling the risk seen with cyclical use.7PubMed. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe
A broader review confirmed the pattern: estrogen alone carries a small increased risk or, in some analyses, no measurable increase at all, while the addition of progestogens pushes the risk higher, with odds ratios ranging from roughly 1.14 to 2.38 depending on the specific type and duration of use.8PubMed Central. Progestins and the Risk of Breast Cancer The practical takeaway is that lumping all hormone therapy into a single risk category is misleading. The formulation, the route of delivery, and the duration all shift the risk profile.
Body Weight and the Estrogen Connection
After menopause, the ovaries stop producing most estrogen. At that point, the main remaining source of estrogen is fat tissue, which contains an enzyme called aromatase that converts other hormones into estrogen. More body fat means more aromatase activity, which means more local estrogen production in and around the breast.9PubMed Central. Aromatase, breast cancer and obesity: a complex interaction This mechanism makes obesity a well-established risk factor specifically for estrogen-receptor-positive breast cancer in postmenopausal women.10PubMed Central. Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression
The relationship before menopause is different and somewhat counterintuitive. Premenopausal obesity is associated with a slightly lower risk for some breast cancer subtypes, possibly because excess weight disrupts ovulation and lowers the frequency of hormonal cycling. This means the obesity-breast cancer story depends heavily on where a woman is in her reproductive life.
Alcohol, Exercise, and Diet
Alcohol is one of the most consistent modifiable risk factors. Even moderate drinking raises breast cancer risk, and the relationship is dose-dependent: the more you drink, the higher the risk. Alcohol acts through several pathways at once. It increases estrogen levels, generates a toxic byproduct called acetaldehyde that can damage DNA directly, produces free radicals, and interferes with folate metabolism, which cells need for proper DNA repair.11PubMed Central. Alcohol and breast cancer: the mechanisms explained No type of alcohol is safer than another; it is the ethanol itself that drives the risk.
Physical activity, on the other hand, is one of the strongest protective behaviors the evidence supports. Regular exercise appears to reduce breast cancer risk through a constellation of effects: it lowers circulating estrogen and insulin, reduces chronic inflammation, improves immune surveillance, and favorably shifts the balance of signaling molecules released by fat and muscle tissue.12PubMed Central. A systematic review of the biological mechanisms linking physical activity and breast cancer A narrative review of the evidence concluded that an active lifestyle provides beneficial effects on all the major biological hallmarks associated with breast cancer.13PubMed Central. Physical Exercise and the Hallmarks of Breast Cancer: A Narrative Review The protection appears to come from sustained, long-term activity rather than occasional intense bursts.
Dietary patterns are harder to study, and the evidence is less definitive than for alcohol or exercise. Mediterranean-style eating patterns, rich in vegetables, fruit, legumes, fish, and olive oil, have been associated with modestly better outcomes in breast cancer survivors, though the magnitude of the effect and the mechanisms behind it remain under investigation.14PubMed Central. The Role of the Mediterranean Diet in Breast Cancer Survivorship: A Systematic Review and Meta-Analysis of Observational Studies and Randomised Controlled Trials
Environmental Chemicals and Endocrine Disruptors
A growing body of research points to endocrine-disrupting chemicals (EDCs) as a contributor to breast cancer risk. These are synthetic compounds that can mimic or block natural hormones by binding to estrogen receptors, progesterone receptors, or other signaling pathways in breast tissue. Chronic exposure, even at low doses, may trigger molecular changes that either initiate cancer or help an existing tumor progress.15PubMed Central. Endocrine Disruptors and Breast Cancer: A Comprehensive Review
Phthalates are a particularly concerning class of EDCs because exposure is so widespread. They are found in plastics, cosmetics, food packaging, and building materials, and people absorb them through ingestion, inhalation, and skin contact. Because the breast is an endocrine-responsive organ, it is especially vulnerable to disruption from these compounds, and emerging evidence links phthalate exposure to breast cancer initiation, progression, and even metastasis.16PubMed Central. Endocrine disruption to metastasis: How phthalates promote breast carcinogenesis A systematic review of epidemiological studies concluded that certain EDC exposures could elevate breast cancer risk, though the long-term and multigenerational effects are still being quantified.17PubMed. Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies
The difficulty with environmental chemical research is that everyone is exposed to dozens of EDCs simultaneously, at varying doses, from different points in life. Isolating the effect of any single chemical is extremely challenging, which is why the evidence, while suggestive and growing, remains less definitive than the evidence for factors like alcohol or hormone therapy.
Night Shift Work and Light Exposure
Working night shifts has been flagged as a breast cancer risk factor, and the proposed mechanism centers on melatonin. Melatonin, the hormone that regulates sleep-wake cycles, also appears to have anti-cancer properties. Light exposure at night suppresses melatonin production, and women who frequently did not sleep during peak melatonin hours showed an increased breast cancer risk.18PubMed. Night shift work, light at night, and risk of breast cancer That foundational study found graveyard shift work was associated with about a 60 percent increase in risk, with the risk climbing alongside more years and more hours per week of overnight work. A more recent analysis reported even steeper numbers, with night shift workers showing roughly 2.6 times the risk of non-night workers.19PubMed Central. How the Intensity of Night Shift Work Affects Breast Cancer Risk
The World Health Organization’s cancer agency (IARC) has classified night shift work as a probable carcinogen, though the relationship is still debated in the literature, partly because it is hard to separate the effects of disrupted sleep from other lifestyle factors common among shift workers.
Ionizing Radiation
Exposure to ionizing radiation is a known breast cancer risk factor. The clearest data come from women who received chest-area radiation therapy at a young age, such as mantle-field radiation for Hodgkin lymphoma. The risk of secondary breast cancer in these women is well documented and can be substantial, particularly when the radiation occurred before age 30.20PubMed Central. A Case Report on Breast Cancer Following Mantle Radiation for Hodgkin Lymphoma: Screening and Management Occupational exposure matters too: a systematic review and meta-analysis found that female physicians with occupational exposure to ionizing radiation had an increased risk of breast cancer compared to unexposed colleagues.21PubMed. Occupational Exposure to Ionizing Radiation in Female Physicians and Breast Cancer Risk: A Systematic Review and Meta-analysis The doses involved in routine screening mammography are very small and are generally considered to be far outweighed by the benefit of early detection for women at average risk.
Breast Density and the Tissue Itself
Dense breast tissue, which shows up as white areas on a mammogram, is one of the strongest independent risk factors for breast cancer. Dense tissue contains more stromal collagen and connective tissue relative to fat. Research has shown a causal link between increased stromal collagen and both tumor formation and metastasis in mammary tissue.22PubMed Central. Collagen density promotes mammary tumor initiation and progression Dense tissue also makes tumors harder to spot on a mammogram, which compounds the problem by delaying detection. Many U.S. states now require that women be informed about their breast density after a mammogram, and supplemental screening with MRI or ultrasound is sometimes recommended for those with extremely dense tissue.
How Aging Rewrites the Playbook
Age is the single biggest risk factor for breast cancer. Part of the reason is simply more time for random mutations to accumulate in breast cells, but epigenetic changes also play a role. As breast tissue ages, chemical tags called methyl groups are added to or removed from DNA in patterns that alter which genes are turned on or off without changing the DNA sequence itself. Researchers have found hundreds of specific sites in normal breast tissue where methylation levels change with age, and these same regions are disproportionately altered in both pre-invasive and invasive breast tumors.23PubMed Central. Normal breast tissue DNA methylation differences at regulatory elements are associated with the cancer risk factor age
Intriguingly, tumor tissue shows a disrupted relationship between biological age (as measured by DNA methylation) and chronological age. In normal breast tissue, the two track closely, but in tumor tissue the correlation breaks down, suggesting that cancer cells undergo a kind of epigenetic “uncoupling” from normal aging.24PubMed Central. DNA methylation age in paired tumor and adjacent normal breast tissue in Chinese women with breast cancer Researchers are now building “epigenetic clocks” that use methylation patterns to predict cancer risk, though these tools are still in early development.25PubMed Central. DNA Methylation, Aging, and Cancer Risk: A Mini-Review
When Genes and Lifestyle Collide
One of the most important practical questions is whether lifestyle choices matter if your genetic risk is already high. The answer is yes. A study using the UK Biobank found that postmenopausal women who followed a favorable lifestyle had about a 30 percent reduction in invasive breast cancer risk regardless of whether their polygenic risk score was low, medium, or high. Among women in the highest genetic risk group, favorable lifestyle habits were associated with a 32 percent reduction in risk.26JNCI: Journal of the National Cancer Institute. Genetic Factors, Adherence to Healthy Lifestyle Behavior, and Risk of Invasive Breast Cancer Among Women in the UK Biobank A separate study specifically of BRCA1 and BRCA2 mutation carriers concluded that lifestyle and environmental factors play a statistically significant role in whether a genetically predisposed woman actually develops cancer.27JNCI Cancer Spectrum. Lifestyle and environmental factors in women carrying BRCA pathogenic variants with and without cancer
This does not mean lifestyle modifications can cancel out a BRCA mutation. But it does mean the fatalistic view that “genes are destiny” is wrong. The interaction between inherited risk and daily choices is real and meaningful.
Different Subtypes, Different Causes
Breast cancer is not a single disease. The molecular subtypes, broadly luminal (hormone-receptor-positive), HER2-overexpressing, and triple-negative, respond differently to hormonal and reproductive risk factors. For example, late menopause and the use of estrogen-plus-progestin hormone therapy are primarily linked to luminal-type disease, while early menarche was found to be specifically associated with HER2-overexpressing tumors. Breastfeeding for six months or more was protective against luminal and triple-negative disease but showed no clear protective effect against HER2-overexpressing breast cancer.28PubMed Central. Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer
This etiological heterogeneity across subtypes, particularly for triple-negative breast cancer, has been confirmed by additional research.29PubMed. The impact of selected risk factors among breast cancer molecular subtypes: a case-only study An evolutionary perspective helps explain the pattern: modern reproductive behaviors like having fewer children and starting later in life are more closely linked to estrogen-receptor-positive breast cancer than to ER-negative disease, suggesting that the “mismatch” between our ancestral reproductive patterns and modern ones primarily drives the hormone-receptor-positive subtypes.30PubMed Central. Modern reproductive patterns associated with estrogen receptor positive but not negative breast cancer susceptibility
Breastfeeding and How Lactation Remodels the Breast
The protective effect of breastfeeding against breast cancer has been observed in study after study, and the biology behind it is becoming clearer. During lactation, breast cells undergo a cycle of milk production, ductal expansion, and then involution, which is the process of the gland returning to its pre-lactation state. This tissue remodeling appears to clear out potentially damaged or mutated cells before they can progress toward cancer.31PubMed Central. Exploring the profound link: Breastfeeding’s impact on alleviating the burden of breast cancer – A review In addition, the fully differentiated breast cells produced during pregnancy and nursing have more efficient DNA repair capabilities and divide more slowly, making them less susceptible to the accumulation of mutations.32PubMed Central. Epigenetic and Immune Mechanisms Linking Breastfeeding to Lower Breast Cancer Rates The more months a woman breastfeeds across her lifetime, the greater the protection tends to be.
Male Breast Cancer
Although breast cancer in men is rare, accounting for less than 1 percent of all breast cancer cases, its causes overlap with and diverge from the female disease in revealing ways. Genetic mutations play a proportionally larger role: harmful variants in cancer-predisposing genes are estimated to be behind 4 to 40 percent of male breast cancers, and genetic testing is now recommended for all men diagnosed with the disease.33PubMed Central. Genetic Landscape of Male Breast Cancer BRCA2 mutations are especially important, with carriers facing roughly 80 times the risk of the general male population. Other risk factors include obesity, testicular diseases, and conditions that shift the estrogen-to-androgen balance.34PubMed. Male breast cancer: an update
The Viral Question
Could viruses contribute to breast cancer? This remains one of the more provocative open questions in the field. Genetic material from several viruses, including human papillomavirus (HPV), Epstein-Barr virus (EBV), and a mouse mammary tumor virus-like agent, has been found in breast tumor samples far more often than in normal breast tissue controls.35PubMed. Viruses and human breast cancer Some of these viruses carry hormone-responsive elements, meaning their replication could be enhanced by the same hormonal environment that promotes breast cancer growth. New computational work has explored whether the immune system’s ability to eliminate certain viruses, based on a person’s specific immune gene variants, could influence which individuals are vulnerable.36PubMed Central. Viruses and breast cancer
The evidence is substantial but not conclusive. No virus has been definitively established as a cause of human breast cancer in the way that HPV causes cervical cancer. If future research confirms a viral role, it could open the door to preventive strategies like vaccination, but for now the data remain in the “intriguing hypothesis” category rather than the “actionable finding” category.